Clinical manifestations of Nephroptosis are ubiquitous. Diagnosis is achieved after ruling out all other causes of abdominal pain by investigations. However, Nuclear Scan with Tc-99m GHA, MAG 3 and DTPA renal agents with dedicated imaging in supine and erect postures confirms the diagnosis5. Not only as a diagnostic aid, it also helps in decision making for surgical correction by depicting the changes in drainage and GFR in different postures. We describe a case of Nephroptosis where DTPA Renal Scintigraphy addressed the diagnostic and therapeutic issues in the case.
Thyroglobulin-elevated negative iodine scan (TENIS) syndrome represents a significant diagnostic and therapeutic challenge. Highly sensitive imaging modalities are required to help in the localization of disease, treatment planning, and prognostication. When compared to other imaging modalities, F-18 fluorodeoxyglucose positron-emission tomography–computed tomography has superior sensitivity and specificity in localizing the disease in this subset of patients. Tumor thrombus of thyroid cancer extending into the great vein is a very rare occurrence and management criteria have not been well established yet. We present a case of TENIS syndrome with tumor thrombus in the superior vena cava.
Skeletal scintigraphy with 99mTc-methylene diphosphonate and 18-fluorine–fluoride the main stay in cancer follow-up for early detection of skeletal metastasis often reveal confusing and conflicting findings requiring proper interpretation in conjunction with clinical-radiological correlation. A series of commonly encountered findings are presented for elucidation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.